MKS Instruments, Inc. (NASDAQ:MKSI) reported revenue of $897 million, surpassing estimates despite an EPS miss.
The company’s EPS of $1.72 exceeded consensus estimates, showcasing its ability to outperform market expectations.
MKSI’s strong financial health is indicated by a high P/E ratio of 250.68 and a current ratio of 3.42.
MKS Instruments, Inc. (NASDAQ:MKSI) is a key player in the technology sector, specializing in instruments, subsystems, and process control solutions. The company serves various markets, including Semiconductor, Electronics & Packaging, and Specialty Industrial. Despite facing competition from companies like Applied Materials and Lam Research, MKSI continues to maintain a strong market presence.
On November 7, 2024, MKSI reported its earnings, revealing an actual earnings per share (EPS) of $1.72, which was above the estimated $1.45. The company achieved revenue of $897 million, surpassing the estimated $874.26 million. This performance highlights MKSI’s ability to generate higher-than-expected revenue and EPS.
During the Q3 2024 earnings call, MKSI’s leadership, including CEO John Lee and CFO Ram Mayampurath, discussed the company’s financial performance and strategic initiatives. The call also featured analysts from financial institutions like Cantor and Wells Fargo. Despite a 3.9% year-over-year revenue decline, MKSI’s revenue exceeded the Zacks Consensus Estimate, delivering a positive surprise of 2.62%.
MKSI’s EPS for the quarter was $1.72, an improvement from the previous year’s $1.46, and it surpassed the consensus estimate of $1.45 by 18%. This indicates MKSI’s capability to outperform market expectations. The company’s strong performance in the Semiconductor and Electronics & Packaging markets contributed to these results.
Financially, MKSI has a high price-to-earnings (P/E) ratio of 250.68, reflecting investor confidence in its earnings potential. The company’s price-to-sales ratio of 2.19 and enterprise value to sales ratio of 3.37 indicate a strong market valuation. With a current ratio of 3.42, MKSI demonstrates good short-term financial health, capable of covering its current liabilities with its assets.
